Following the publication of the Review by Xavier M Keutgen, Filippo Filicori and Thomas J Fahey III: ‘Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration’, published in the July 2013 issue of Expert Review of Molecular Diagnostics (Expert Rev. Mol. Diag. 13[6], 613–623 [2013]), it has been brought to our attention that information on page 615 has been incorrectly reported.
The Asuragen miRInform® Thyroid Test is not approved by the FDA and so the sentence “Recently, the US FDA approved a panel comprising all the aforementioned mutations for clinical use [31].” should be removed from the paragraph entitled ‘The MiRInform tm panel by Asuragen’.
Expert Review of Molecular Diagnostics sincerely apologize for any inconvenience caused by this error.